Opioid and Benzodiazepine Use in End-Stage Renal Disease | Zendy

Ahraaz Wyne | Zendy; Raman Rai | Zendy; Meaghan S. Cuerden | Zendy; William F. Clark | Zendy; Rita S. Suri | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Opioid and Benzodiazepine Use in End-Stage Renal Disease

Author(s) -

Ahraaz Wyne,

Raman Rai,

Meaghan S. Cuerden,

William F. Clark,

Rita S. Suri

Publication year - 2010

Publication title -

clinical journal of the american society of nephrology

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 2.755

H-Index - 151

eISSN - 1555-905X

pISSN - 1555-9041

DOI - 10.2215/cjn.04770610

Subject(s) - medicine , benzodiazepine , adverse effect , incidence (geometry) , opioid , dialysis , cinahl , medical prescription , emergency medicine , pediatrics , psychiatry , pharmacology , psychological intervention , receptor , physics , optics

Chronic pain and psychiatric disorders are common in dialysis patients, but the extent to which opioids and benzodiazepines are used is unclear. We conducted a systematic review to determine the: (1) prevalence of opioid and benzodiazepine use among dialysis patients; (2) reasons for use; (3) effectiveness of symptom control; and (4) incidence of adverse events.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research